Zibo Shandong Province, China
Adult Screening for Hepatitis c and Linkage to Treatment in Hospitals in Colombia
Research question ¿What is the prevalence of HCV in the population with risk factors for hepatitis C virus infection captured by screening with rapid tests in health care institutions in Colombia? Through this observational, multicenter, hospital population study, the prevalence will be determined by screening patients with risk factors for hepatitis C by rapid antibody test, to subsequently perform confirmation with viral load PCR in those seropositive. In addition, support will be provided to patients to facilitate their treatment adherence. The benefits would be related to raising awareness of the importance of the active search for these patients, reducing the health impact for the screened population, incorporating these strategies in the country's hospital institutions, and obtaining epidemiological information that helps to understand the magnitude of the disease and the opportunity for its elimination.
Phase
N/ASpan
55 weeksSponsor
Asociación Colombiana de HepatologíaSanta Marta, Magdalena
Recruiting
Healthy Volunteers
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Phase
3Span
205 weeksSponsor
Boehringer IngelheimSanta Marta
Recruiting
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Phase
3Span
197 weeksSponsor
Boehringer IngelheimSanta Marta
Recruiting